Subgroup analysis according to the current categorization of eligible disease modifying therapies as “first line” and “second line” drug options for the treatment of relapsing-remitting multiple sclerosis.
收藏NIAID Data Ecosystem2026-03-09 收录
下载链接：
https://figshare.com/articles/dataset/_Subgroup_analysis_according_to_the_current_categorization_of_eligible_disease_modifying_therapies_as_8220_first_line_8221_and_8220_second_line_8221_drug_options_for_the_treatment_of_relapsing_remitting_multiple_sclerosis_/1620196
下载链接
链接失效反馈官方服务：
资源简介：
Subgroup analysis according to the current categorization of eligible disease modifying therapies as “first line” and “second line” drug options for the treatment of relapsing-remitting multiple sclerosis.
创建时间：
2015-12-07
